Scaling up, characterization of levan and its inhibitory role in carcinogenesis initiation stage'

被引:50
作者
Esawy, Mona A. [1 ]
Amer, Hassan [1 ,2 ]
Gamal-Eldeen, Amira M. [3 ]
El Enshasy, Hesham A. [4 ,5 ]
Helmy, Wafaa A. [1 ]
Abo-Zeid, Mona A. M. [6 ]
Malek, Roslinda [4 ]
Ahmed, Eman F. [1 ]
Awad, Ghada E. A. [1 ]
机构
[1] Natl Res Ctr, Dept Chem Nat & Microbial Prod, Giza, Egypt
[2] UFT Haus Univ & For SchungszentrumTulln UFT, Dept Chem, A-3430 Tullnan Der Donau, Austria
[3] Natl Res Ctr, Dept Biochem, Canc Biol Lab, Ctr Excellence Adv Sci, Giza, Egypt
[4] UTM, IBD, Skudai, Johor, Malaysia
[5] City Sci Res & Technol Applicat CSAT, Alexandria, Egypt
[6] Natl Res Ctr, Genet & Cytol Dept, Canc Biol Lab, Ctr Excellence Adv Sci, Cairo 12622, Egypt
关键词
Levan; Levansucrase; Bacillus subtilis; Cancer protective; Bioreactor; LEVANSUCRASE; FRUCTOOLIGOSACCHARIDES; APOPTOSIS; MECHANISM; THERAPY; CELLS;
D O I
10.1016/j.carbpol.2013.02.079
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Honey isolate Bacillus subtilis M was cultivated in shake flasks and in 16-l bioreactor cultures to investigate cell growth, bio-metabolites production kinetics and bioprocess scalability. The respective maximal levan and levansucrase productions of 59.5 g/l and 74.1 U/ml were achieved in bioreactor cultures under pH controlled condition (pH = 7.0) after only 24h. Crude levan (levE) was isolated, characterized and fractionated into F1, F2, and F3 with different molecular weight (21.8, 13.118, 9.53 kDa). H-1 NMR and C-13 NMR spectroscopy proved that LevE and their fractions were mainly beta-(2, 6)-linked levan-type polysaccharide. The cancer chemo-preventive activity indicated that the levE and its fraction 3 were promising inhibitors of cytochrome P-450 1A activity, inducers of glutathione-S-transferase activity in Murine hepatomaHepa1c1c7cells and possessed highest radical scavenging affinity to both ROO center dot and OH center dot. They inhibited the induced-DNA fragmentation. None of the tested samples triggered apoptosis or necrosis in splenocytes, except F2. (c) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:578 / 587
页数:10
相关论文
共 45 条
[1]   Production of levansucrase from Bacillus subtilis NRC 33a and enzymic synthesis of levan and fructo-oligosaccharides [J].
Abdel-Fattah, AF ;
Mahmoud, DAR ;
Esawy, MAT .
CURRENT MICROBIOLOGY, 2005, 51 (06) :402-407
[2]   Antitumor and antioxidant activities of levan and its derivative from the isolate Bacillus subtilis NRC1aza [J].
Abdel-Fattah, Aza M. ;
Gamal-Eldeen, Amira M. ;
Helmy, Wafaa A. ;
Esawy, Mona A. .
CARBOHYDRATE POLYMERS, 2012, 89 (02) :314-322
[3]   Molecular targets of dietary agents for prevention and therapy of cancer [J].
Aggarwal, BB ;
Shishodia, S .
BIOCHEMICAL PHARMACOLOGY, 2006, 71 (10) :1397-1421
[4]  
Anne S. T., 2006, J CLIN INVEST, V54, P150
[5]  
Bertram John S., 2000, Molecular Aspects of Medicine, V21, P167, DOI 10.1016/S0098-2997(00)00007-8
[6]  
Block R. J., 1995, MANUAL PAPER CHROMAT, P127
[8]   Expression and activity of microsomal epoxide hydrolase in follicles isolated from mouse ovaries [J].
Cannady, EA ;
Dyer, CA ;
Christian, PJ ;
Sipes, IG ;
Hoyer, PB .
TOXICOLOGICAL SCIENCES, 2002, 68 (01) :24-31
[9]  
Cao GH, 1999, METHOD ENZYMOL, V299, P50
[10]   Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450 [J].
Crespi, CL ;
Miller, VP ;
Penman, BW .
ANALYTICAL BIOCHEMISTRY, 1997, 248 (01) :188-190